HIVE vs ESPR

Comparison between HIVE Digital Technologies Ltd (HIVE, Company) and Esperion Therapeutics Inc (ESPR, Company).

HIVE is from the Financial Services sector, while ESPR is from the Healthcare sector.

5-Year PerformanceHIVE has outperformed ESPR, delivering a return of -20.8% compared to -34.6%

HIVE vs ESPR - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	HIVE(COMPANY)	ESPR(COMPANY)
Market Cap	$789M	$789M
Max Drawdown	97.73%	99.37%
Sharpe Ratio	1.08	1.40
5Y Beta	2.71	1.34
Industry	Capital Markets	Drug Manufacturers - Specialty & Generic
P/E Ratio	-5.31	-5.96
Forward P/E	62.89	4.64
PEG Ratio	-0.00	-0.74
5Y EPS CAGR	N/A	-31.57%
Debt to Equity	0.38%	0.00%
Free Cash Flow Yield	7.90%	-2.33%
P/S Ratio	3.80	1.94
P/B Ratio	1.77	98.42

Market Cap

HIVE

$789M

Winner

ESPR

$789M

Max Drawdown

Winner

HIVE

97.73%

ESPR

99.37%

Sharpe Ratio

HIVE

1.08

Winner

ESPR

1.40

5Y Beta

HIVE

2.71

Winner

ESPR

1.34

Industry

HIVE

Capital Markets

ESPR

Drug Manufacturers - Specialty & Generic

P/E Ratio

HIVE

-5.31

Winner

ESPR

-5.96

Forward P/E

HIVE

62.89

Winner

ESPR

4.64

PEG Ratio

HIVE

-0.00

Winner

ESPR

-0.74

5Y EPS CAGR

HIVE

N/A

ESPR

-31.57%

Debt to Equity

HIVE

0.38%

Winner

ESPR

0.00%

Free Cash Flow Yield

Winner

HIVE

7.90%

ESPR

-2.33%

P/S Ratio

HIVE

3.80

Winner

ESPR

1.94

P/B Ratio

Winner

HIVE

1.77

ESPR

98.42

HIVE vs ESPR - Historical Returns

Returns include dividend reinvestment.

Period	HIVE	ESPR
1 month	+32.27%	+0.64%
3 months	+79.33%	+27.53%
6 months	+21.90%	-18.18%
1 year	+91.28%	+162.50%
5 years(CAGR)	-20.83%	-34.61%
10 years(CAGR)	-13.95%	-15.10%
Max(CAGR)	-13.95%	-11.11%

Winner

HIVE

+32.27%

ESPR

+0.64%

Winner

HIVE

+79.33%

ESPR

+27.53%

Winner

HIVE

+21.90%

ESPR

-18.18%

HIVE

+91.28%

Winner

ESPR

+162.50%

5Y(CAGR)

Winner

HIVE

-20.83%

ESPR

-34.61%

10Y(CAGR)

Winner

HIVE

-13.95%

ESPR

-15.10%

Max(CAGR)

HIVE

-13.95%

Winner

ESPR

-11.11%

HIVE vs ESPR - Annual Returns (2013 - 2026)

Returns include dividend reinvestment.

Year	HIVE	ESPR
2026	+36.63%	-15.09%
2025	-16.50%	+68.18%
2024	-35.08%	-24.66%
2023	+196.08%	-48.80%
2022	-89.17%	+20.04%
2021	+35.38%	-81.96%
2020	+2600.00%	-57.61%
2019	-66.95%	+30.45%
2018	-92.61%	-30.83%
2017	N/A	+411.18%
2016	N/A	-42.17%
2015	N/A	-46.01%
2014	N/A	+191.35%
2013	N/A	-5.24%

HIVE vs ESPR Drawdown Comparison

The maximum drawdown for HIVE was -97.73%, occurring on Dec 17, 2019. Recovery took 752 trading sessions.

The maximum drawdown for ESPR was -99.37%, occurring on May 14, 2025. This drawdown has not yet recovered.

The current HIVE drawdown is -86.10%. The current ESPR drawdown is -97.27%.

Rank	HIVE	ESPR
#1	-97.73% Jan 12, 2018 - Jan 8, 2021	-99.37% May 19, 2015 - May 14, 2025
#2	-95.12% Feb 19, 2021 - Apr 8, 2025	-41.24% Oct 2, 2013 - Sep 26, 2014
#3	-32.45% Jan 8, 2021 - Feb 12, 2021	-28.66% Oct 8, 2014 - Oct 31, 2014
#4	N/A	-22.60% Mar 23, 2015 - May 19, 2015
#5	N/A	-18.82% Aug 5, 2013 - Sep 26, 2013
#6	N/A	-13.95% Oct 31, 2014 - Nov 12, 2014
#7	N/A	-12.84% Jan 14, 2015 - Feb 3, 2015
#8	N/A	-12.54% Dec 9, 2014 - Dec 31, 2014
#9	N/A	-12.35% Feb 18, 2015 - Mar 12, 2015
#10	N/A	-10.06% Nov 18, 2014 - Dec 4, 2014
#11	N/A	-6.74% Jan 12, 2015 - Jan 14, 2015
#12	N/A	-6.30% Jan 8, 2015 - Jan 12, 2015
#13	N/A	-3.45% Jun 26, 2013 - Jul 2, 2013
#14	N/A	-3.06% Jul 16, 2013 - Jul 29, 2013
#15	N/A	-2.87% Sep 26, 2014 - Sep 30, 2014